Two Long-Time Volunteers Elected to Lead Breakthrough T1D International Board of Directors
The Breakthrough T1D International Board of Directors (IBOD) named two long-time volunteers to serve as Chair and Vice Chair when…
Breakthrough T1D Mission Summit Salutes Type 1 Diabetes Research
Ellen Leake, Chair of the International Board of Directors
Where Are They Now? Derek and Emily Rapp Seek to Grow Support for Breakthrough T1D
When Derek Rapp stepped down as President and CEO of Breakthrough T1D last year, he vowed he’d never be far…
State of the Foundation: Inspiring T1D Champions | Accelerating Cures
By Aaron J. Kowalski, Ph.D.President and CEO, Breakthrough T1D I don’t remember a time when type 1 diabetes (T1D) was…
A Team in Boston Trying to Prevent Type 1 Diabetes
Breakthrough T1D is funding work on multiple ways to delay or prevent the onset of type 1 diabetes (T1D). This…
One Scientist’s Plan to Regenerate Beta Cells in Boston
Can we internally regenerate and protect beta cells, and therefore find cures for type 1 diabetes (T1D)? One scientist thinks…
Get To Know the Key People Behind Beta Cell Replacement Therapy in Boston
Join us for an inside look at the collaborations and skills that researchers in Boston are using to tackle the…
Join Us “Inside the Lab at Boston”
The work of type 1 diabetes (T1D) researchers is so compelling and full of hope. But it also is a…
A Win for the European T1D Community: Zynquista (sotagliflozin) Approved for Type 1 Diabetes
In a second win for the type 1 diabetes (T1D) community, the European Commission has approved Zynquista™ (sotagliflozin) for use…
Breakthrough T1D Names Aaron Kowalski New President and CEO
Chief Mission Officer to assume leadership baton from Derek Rapp After a thorough national search, the Breakthrough T1D International Board…
